Total Shoulder Athroplasty Clinical Trial
The Effect of Tranexamic Acid in Anticoagulated Patients Undergoing Total Shoulder Athroplasty
This is a randomized, single-blind, single-center study comparing calculated total blood loss, surgical drain output and hematoma formation in anticoagulated patients who receive 2 doses of Tranexamic Acid (TXA) versus control group undergoing anatomical and reverse total shoulder arthroplasty. Patients will be randomized to either receive 2 doses of IV TXA, first dose prior to surgical incision and second dose given 3 hours later or to the control group, where no TXA will be administered.
|Source||NYU Langone Health|
|Start date||October 6, 2020|
|Completion date||March 11, 2023|